Natural history of celiac disease autoimmunity in a USA cohort followed since 1974

Annals of Medicine

Volumn 42, Issue 7, 2010, Pages 530-538

  Catassi, Carlo ^a,b   Kryszak, Debby ^a   Bhatti, Bushra ^a   Sturgeon, Craig ^a   Helzlsouer, Kathy ^c   Clipp, Sandra L ^c   Gelfond, Daniel ^d   Puppa, Elaine ^a   Sferruzza, Anthony ^e   Fasano, Alessio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CHILDREN S HOSPITAL OF BUFFALO   (United States)

^e QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Auto antibodies; celiac disease; epidemiology; natural history of disease; prevalence

Indexed keywords

AUTOANTIBODY; ENDOMYSIUM ANTIBODY; GLUTEN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELIAC DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELIAC DISEASE; COHORT STUDIES; COMORBIDITY; GLUTENS; GTP-BINDING PROTEINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY; TRANSGLUTAMINASES; UNITED STATES; YOUNG ADULT;

EID: 77958023807     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.514285     Document Type: Article

References (32)

1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroen-terology. 2001;120:636-51.
2. Barton SH, Murray JA. Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am. 2008;37:411-28.
3. Health, NIo 2003. Autoimmune Disease Research Plan. Available at: http://www.niaid.nih.gov/dait/pdf/ADCCReport.pdf. Date accessed: April 2, 2010
4. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286-92.
5. Catassi C, R ä tsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994;343:200-3.
6. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217-25.
7. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, et al. Increased Prevalence and Mortality in Undi-agnosed Celiac Disease. Gastroenterology. 2009;137:88-93.
8. Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman SC, Strickland PT, Brock JW, et al. Serum concentrations of organo-chlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:525-32.
9. Fernandez E, Blanco C, Garcia S, Dieguez A, Riestra S, Rodrigo L. Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA defi ciency in patients with suspected celiac disease. Clin Chem. 2005;51:1014-6.
10. AGA Institute. AGA Institute medical position statement on the diagnosis and management of celiac disease. Gastroen-terology. 2006;131:1977-80.
11. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serological tests for celiac disease: a systematic review. Gastroenterology. 2005;128 (4 Suppl 1):S38-46.
12. Baudon JJ, Johanet C, Absalon YB, Morgant G, Cabrol S, Mougenot JF. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies. Arch Pediatr Adolesc Med. 2004;158:584-8.
13. Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confi rmed study with economic analysis. Clin Gastroenterol Hepatol. 2008;6:314-20.
14. Hadithi M, von Blomberg BM, Crusius JB, Bloemena E, Kostense PJ, Meijer JW, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147:294-302.
15. Paparo F, Petrone E, Tosco A, Maglio M, Borrelli M, Salvati VM, et al. Clinical, HLA, and small bowel immunohisto-chemical features of children with positive antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol. 2005;100:2294-8.
16. Kaukinen K, Collin P, M ä ki M. Latent coeliac disease or coeliac disease beyond atrophy? Gut. 2007;56: 1339-40.
17. Vilppula A, Kaukinen K, Luostarinen L, Krekel ä I, Patrikainen H, Valve R, et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol. 2009;9:49.
18. Olsson C, Hernell O, H ö rnell A, L ö nnberg G, Ivarsson A. Difference in celiac disease risk between Swedish birth cohorts suggests an opportunity for primary prevention. Pediatrics. 2008;122:528-34.
19. Goldberg D, Kryszak D, Fasano A, Green PH. Screening for celiac disease in family members: is follow-up testing necessary? Dig Dis Sci. 2007;52:1082-6.
20. Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics. 2002;109:833-8.
21. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA. 2005;293:2343-51.
22. Simell S, Kupila A, Hoppu S, Hekkala A, Simell T, St ä hlberg MR, et al. Natural history of transglutaminase autoantibod-ies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol. 2005; 40:1182-91.
23. Vilppula A, Collin P, M ä ki M, Valve R, Luostarinen M, Krekel ä I, et al. Undetected coeliac disease in the elderly: a biopsy-proven population-based study. Dig Liver Dis. 2008;40:809-13.
24. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-20.
25. Ivarsson A, Persson LA, Nystr ö m L, Ascher H, Cavell B, Danielsson L, et al. Epidemic of coeliac disease in Swedish children. Acta Paediatr. 2000;89:165-71.
26. Gobbetti M, Rizzello GM, Di Cagno R, De Angelis M. Sourdough lactobacilli and celiac disease. Food Microbiol. 2007; 24:187-96.
27. Zanoni G, Navone R, Lunari C, Tridente G, Bason C, Sivori S, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006;3:e358.
28. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther. 2008; 27:572-7.
29. Simell S, Hoppu S, Hekkala A, Simell T, St å hlberg ML, Viander M, et al. Fate of fi ve celiac disease associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastro-enterol. 2007;102:2026-35.
30. Ferrara F, Quaglia S, Caputo I, Esposito C, Lepretti M, Pastore S, et al. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin Exp Immunol. 2009;159:217-23.
31. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphoma and other cancers. Gastroenterol-ogy. 2005;128 (4 Suppl 1):S79-86.
32. Viljamaa M, Kaukinen K, Huhtala H, Kir ö npalo S, Rasmussen M, Collin P. Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol. 2005;40:437-43.